Carlsmed, Inc. (CARL) vs REGENXBIO Inc. (RGNX)
A side-by-side comparison of Carlsmed, Inc. and REGENXBIO Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CARL
Carlsmed, Inc.
$14.86HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
RGNX
REGENXBIO Inc.
$7.55HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — CARL vs RGNX
growth of $100 · dividends reinvested · last 1yCARL +5.5% (+5.5%/yr)RGNX -14.6% (-14.6%/yr)CARL compounded faster over this window
CARL RGNX
CARL vs RGNX: by the numbers
- •CARL is the larger company ($404M vs $390M market cap).
- •Both run net losses; CARL's is the smaller (-57.42% vs -112.58% net margin).
Metrics side by side
Valuation
| Metric | CARL | RGNX |
|---|---|---|
| P/S ratio | 6.38 | 2.24 |
| P/B ratio | 4.80 | 5.44 |
Profitability
| Metric | CARL | RGNX |
|---|---|---|
| Gross margin | 76.63% | 88.09% |
| Operating margin | -61.09% | -94.08% |
| Net margin | -57.42% | -112.58% |
| ROE | -43.14% | -273.72% |
| ROIC | -36.54% | -54.00% |
Growth (annualized)
| Metric | CARL | RGNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.59% |
| Total return CAGR (5Y) | N/A | -24.15% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.